Johnson & Johnson expects to complete Actelion purchase on June 16 Johnson & Johnson (JNJ.N) said the approval of its proposed acquisition of Swiss biotech firm Actelion (ATLN.S) by the European Commission on Friday meant all regulatory approvals required to complete the $30 billion deal had now been received. The […]
